SCHEMBL4584849

SCHEMBL4584849

CC(C)(C)OC(=O)N1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.60
CSNK1D P48730 1/20 0.60
RPS6KA3 P51812 1/20 0.60
MAPK14 Q16539 10/20 0.60
MAPK11 Q15759 9/20 0.60
MAPK13 O15264 8/20 0.60
MAPK12 P53778 8/20 0.60
RAF1 P04049 3/20 0.60
MAPK9 P45984 3/20 0.60
KCNH2 Q12809 1/20 0.49
GPR119 Q8TDV5 2/20 0.48
BRAF P15056 1/20 0.47
ALOX5 P09917 1/20 0.46
GCGR P47871 1/20 0.46
HPGDS O60760 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025352 1.00 CSNK1A1 (0.60) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL4028406 0.90 MAPK14 (0.59) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL8551836 0.88 CSNK1A1 (0.46) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL8638666 0.88 CSNK1A1 (0.61) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL4033802 0.87 CSNK1A1 (0.58) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL4025214 0.86 CSNK1A1 (0.67) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL4025331 0.86 CSNK1A1 (0.67) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL4026671 0.85 MAPK11 (0.68) CSNK1A1CSNK1DRPS6KA3MAPK14MAPK11
SCHEMBL3099823 0.84 HTT (0.59) GPR119HPGDS
SCHEMBL27538196 0.84 MAPK14 (0.47) CSNK1A1CSNK1DRPS6KA3MAPK14GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539121-A4 METHODS OF PROMOTING OSTEOGENESIS SCIOS INC (US) 2008-08-13 EP disclosed
EP-1545535-A4 TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE SCIOS INC (US) 2008-06-04 EP disclosed
EP-1583535-A4 METHODS FOR TREATING DIABETES SCIOS INC (US) 2008-03-19 EP disclosed
EP-1583535-A2 METHODS FOR TREATING DIABETES SCIOS INC. (US) 2005-10-12 EP disclosed
EP-1545535-A2 TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE SCIOS INC. (US) 2005-06-29 EP disclosed
EP-1539121-A2 METHODS OF PROMOTING OSTEOGENESIS SCIOS INC. (US) 2005-06-15 EP disclosed
WO-2005032551-A1 TREATMENT OF CARDIOVASCULAR DISEASE WITH INHIBITORS OF p38 KINASE SCIOS INC. (US) 2005-04-14 WO disclosed
WO-2004019873-A9 METHODS OF PROMOTING OSTEOGENESIS SCIOS INC (US) 2004-06-24 WO disclosed
WO-2004053107-A2 METHODS FOR TREATING DIABETES SCIOS INC. (US) 2004-06-24 WO disclosed
WO-2004021988-A2 TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE SCIOS INC. (US) 2004-03-18 WO disclosed
WO-2004019873-A2 METHODS OF PROMOTING OSTEOGENESIS SCIOS INC. (US) 2004-03-11 WO disclosed